Website News and Research

RSS

Transposagen Biopharmaceuticals announces new TGEM Rat Model product line

Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it has added 170 genetically modified rats and related biomaterials to its database of laboratory rats with a genetic modification that can mimic a human disease. These animals are used by academic, pharmaceutical, and biotech scientists for drug discovery and development research and will be sold under Transposagen's new TGEM(TM) Rat Models brand.

23 Apr 2010

Nile Therapeutics prices underwritten public offering of common stock

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced the pricing of its previously announced underwritten public offering of 6,500,000 units of its securities at a public offering price of $0.70 per unit. Each unit consists of one share of Nile common stock and 0.30 warrants to purchase common stock.

23 Apr 2010

COSMOS project launched to investigate link between use of mobile phones and health problems

A new decades-long study launches today to investigate whether there is a link between the use of mobile phones and long-term health problems such as cancer.

23 Apr 2010

Researchers use electronic medical records for injury management and surveillance during marathon

Henry Ford Hospital researchers have brought the use of electronic medical records out of the hospital setting and into the streets by using the technology for a marathon.

23 Apr 2010

Website launched to track aid to Haiti from 'pledge to impact'

Agence France-Presse reports that the U.N. has launched "a new website to track the estimated 9.9 billion dollars in aid pledged to Haiti by the international community in the wake of a devastating January 12 earthquake." The website is a joint project of the Haitian government and the U.N. Development Programme.

23 Apr 2010

Align Technology reports 28.5% increase year-over-year in first-quarter revenues

Align Technology, Inc. today reported financial results for the first quarter of fiscal 2010, ended March 31, 2010.

22 Apr 2010

CancerDrugsDirect.com provides customers access to affordable cancer medications

When someone is diagnosed with cancer, the effects can be devastating both physically as well as financially. Recent studies have shown that many cancer patients are foregoing care because of the skyrocketing cost of cancer treatments.

22 Apr 2010

Halo Benefits introduces new pharmacy prescription card that offers discounts to consumers

Halo Benefits, Inc., a subsidiary of Halo Companies, Inc., announced today that it now offers HaloRx, a pharmacy prescription card that offers discounts to consumers. The new discount card is offered now at a time when the cost of prescription drugs is at a record high. "We are excited about the opportunity to offer more affordable options to consumers with medication needs.

22 Apr 2010

Life sciences companies shifting away from traditional document management systems to emerging ECC solutions

Virtify, Inc., today announced the availability of a new IDC Health Insights study titled "Managing Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance." The new IDC Health Insights study, which was commissioned by Virtify, shows a growing trend in the life sciences industry away from traditional document management systems to emerging Enterprise Content Compliance (ECC) solutions.

22 Apr 2010

Senate Subcommittee hearing looks at USAID budget request, potential for reform

A Senate Appropriations Subcommittee on State, Foreign Operations and Related Programs hearing on Tuesday about USAID's FY 2011 budget addressed the potential for "broad changes in the culture and operations of" USAID, CQ reports.

22 Apr 2010

Conference on how to develop networks to improve patient safety

The LINNEAUS collaboration is a group of primary care professionals and researchers from the UK, Netherlands, Denmark, Germany, Austria and Poland who have significant experience in understanding and learning about patient safety.

22 Apr 2010

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Salix Pharmaceuticals, Ltd. today announced that the Company will host a DDW2010 Investor Event on Monday, May 3 2010 from 9:00 p.m. to 10:00 p.m. Central Time (10:00 p.m. to 11:00 p.m. ET).

22 Apr 2010

Health Grades' ratings and advisory revenue for first-quarter up 20%

Health Grades, Inc., the leading independent healthcare ratings company, today reported financial results for the first quarter ended March 31, 2010.

21 Apr 2010

Alchemia’s HyACT tumour targeting technology enhances killing of cancer stem cells

Alchemia's subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The data demonstrates the ability of the Company's HyACT tumour targeting technology to dramatically enhance the killing of cancer stem cells. These cells are highly resistant to treatment with chemotherapeutic drugs and are believed to be responsible for treatment failure and disease recurrence.

21 Apr 2010

Evening of Remembrance Memorial Services to be offered in Colma, Palo Alto and Hayward

Pathways Home Health & Hospice is offering Evening of Remembrance Memorial Services in Colma, Palo Alto and Hayward in May. Individuals and families who are grieving will find a place to remember, reflect and honor their lost loved ones.

21 Apr 2010

Preclinical data in neuroblastoma for perifosine to be presented at AACR 2010 Meeting

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that preclinical data in neuroblastoma for perifosine, the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, will be presented at the 101st Annual Meeting of the American Association for Cancer Research, currently being held at the Walter E. Washington Convention Center in Washington, DC.

21 Apr 2010

Vitamin D intake from foods, supplements may not predict relationship between cancer and vitamin D

Vitamin supplements, diet, geographic location, demographic information or lifestyle, independently or in combination, cannot accurately predict vitamin D concentrations in blood, researchers at the University at Buffalo have found.

21 Apr 2010

Nutrition experts call for sodium reduction strategies

Responding to the health threat posed by Americans' over-consumption of sodium, experts in the department of nutrition at Harvard School of Public Health (HSPH) and The Culinary Institute of America (CIA) called today for sodium reduction strategies that are strong and effective-and that maximize the enjoyment people derive from food.

21 Apr 2010

Effects of UV radiation may increase chance of developing eye problems later in life

While 85 percent of Americans recognize that ultraviolet rays can damage their eyes, only 65 percent wear sunglasses as protection, and even fewer (39 percent) make sure their children wear sunglasses. By comparison, 78 percent make sure their children wear sunscreen when outdoors.

21 Apr 2010

Celsion's ThermoDox Phase I trial data presented at 9th IHPBA World Congress

Celsion Corporation today announced that Dr. Thanjavur S. Ravikumar, from the Geisinger Health System and a principal investigator of the Phase I ThermoDox® dose escalation trial, gave an oral presentation at the Liver Tumors Panel session of the 9th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA) in Buenos Aires, Argentina.

21 Apr 2010

Website News and Research

Transposagen Biopharmaceuticals announces new TGEM Rat Model product line

Nile Therapeutics prices underwritten public offering of common stock

COSMOS project launched to investigate link between use of mobile phones and health problems

Researchers use electronic medical records for injury management and surveillance during marathon

Website launched to track aid to Haiti from 'pledge to impact'

Align Technology reports 28.5% increase year-over-year in first-quarter revenues

CancerDrugsDirect.com provides customers access to affordable cancer medications

Halo Benefits introduces new pharmacy prescription card that offers discounts to consumers

Life sciences companies shifting away from traditional document management systems to emerging ECC solutions

Senate Subcommittee hearing looks at USAID budget request, potential for reform

Conference on how to develop networks to improve patient safety

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Health Grades' ratings and advisory revenue for first-quarter up 20%

Alchemia’s HyACT tumour targeting technology enhances killing of cancer stem cells

Evening of Remembrance Memorial Services to be offered in Colma, Palo Alto and Hayward

Preclinical data in neuroblastoma for perifosine to be presented at AACR 2010 Meeting

Vitamin D intake from foods, supplements may not predict relationship between cancer and vitamin D

Nutrition experts call for sodium reduction strategies

Effects of UV radiation may increase chance of developing eye problems later in life

Celsion's ThermoDox Phase I trial data presented at 9th IHPBA World Congress

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News